Conversion of CD4+ CD25- cells into CD4+ CD25+ regulatory T cells in vivo requires B7 costimulation, but not the thymus

Journal of Experimental Medicine

Volumn 201, Issue 1, 2005, Pages 127-137

  Liang, Shuang ^a   Alard, Pascale ^a   Zhao, Yuan ^a   Parnell, Sarah ^a   Clark, Sherry L ^a   Kosiewicz, Michele M ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; B7 GENE; CELL MATURATION; CELL POPULATION; CELL PROLIFERATION; CELL TRANSFER; CELL TRANSFORMATION; CONGENIC STRAIN; CONTROLLED STUDY; FEMALE; FOXP3 GENE; GENE; GENE EXPRESSION; IMMUNOSTIMULATION; IN VITRO STUDY; IN VIVO STUDY; LYMPHOID ORGAN; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; THYMECTOMY; THYMUS;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD80; AUTOIMMUNE DISEASES; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; DNA PRIMERS; DNA-BINDING PROTEINS; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; LYMPHOID TISSUE; MICE; MICE, INBRED C57BL; RECEPTORS, INTERLEUKIN-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTE SUBSETS;

EID: 12344307563     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20041201     Document Type: Article

References (31)

1. Asano, M., M. Toda, N. Sakaguchi, and S. Sakaguchi. 1996. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med. 184:387-396.
2. Sakaguchi, S., N. Sakaguchi, M. Asano, M. Itoh, and M. Toda. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155:1151-1164.
3. + naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J. Immunol. 162:5317-5326.
4. + immunoregulatory T cells. J. Exp. Med. 194:427-438.
5. + regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2:301-306.
6. Apostolou, I., A. Sarukhan, L. Klein, and H. von Boehmer. 2002. Origin of regulatory T cells with known specificity for antigen. Nat. Immunol. 3:756-763.
7. + T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen. J. Immunol. 167:188-195.
8. + regulatory T cells. Nat. Immunol. 4:330-336.
9. Hori, S., T. Nomura, and S. Sakaguchi. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science. 299:1057-1061.
10. + T regulatory cells. Nat. Immunol. 4:337-342.
11. + regulatory T cells. Proc. Natl. Acad. Sci. USA. 99:13031-13036.
12. Mason, D., and F. Powrie. 1998. Control of immune pathology by regulatory T cells. Curr. Opin. Immunol. 10:649-655.
13. + immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity. 16:311-323.
14. + regulatory cells that control intestinal inflammation. J. Exp. Med. 192:295-302.
15. + regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol. 3:135-142.
16. + splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7. J. Immunol. 169:2461-2465.
17. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192:303-310.
18. + suppressor T cells in vivo. Nat. Immunol. 3:33-41.
19. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10:1969-1980.
20. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188:287-296.
21. + regulatory T cells is mediated by cell surface-bound transforming growth factor β. J. Exp. Med. 194:629-644.
22. + regulatory T cells can mediate suppressor function in the absence of transforming growth factor β1 production and responsiveness. J. Exp. Med. 196:237-246.
23. Surh, C.D., J. Sprent, and S.R. Webb. 1993. Exclusion of circulating T cells from the thymus does not apply in the neonatal period. J. Exp. Med. 177:379-385.
24. Lohr, J., B. Knoechel, S. Jiang, A.H. Sharpe, and A.K. Abbas. 2003. The inhibitory function of B7 costimulators in T cell responses to foreign and self-antigens. Nat. Immunol. 4:664-669.
25. + immunoregulatory T cells that control autoimmune diabetes. Immunity. 12:431-440.
26. + regulatory T cells. J. Immunol. 171:3348-3352.
27. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198:1875-1886.
28. - cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10. J. Immunol. 172:5213-5221.
29. Tanchot, C., M.M. Rosado, F. Agenes, A.A. Freitas, and B. Rocha. 1997. Lymphocyte homeostasis. Semin. Immunol. 9:331-337.
30. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22:531-562.
31. Apostolou, I., and H. von Boehmer. 2004. In vivo instruction of suppressor commitment in naive T cells. J. Exp. Med. 199:1401-1408.